DK107168C - Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-2(1H)-oner. - Google Patents

Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-2(1H)-oner.

Info

Publication number
DK107168C
DK107168C DK303962AA DK303962A DK107168C DK 107168 C DK107168 C DK 107168C DK 303962A A DK303962A A DK 303962AA DK 303962 A DK303962 A DK 303962A DK 107168 C DK107168 C DK 107168C
Authority
DK
Denmark
Prior art keywords
benzodiazepin
aryl
ones
preparation
Prior art date
Application number
DK303962AA
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK107168C publication Critical patent/DK107168C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/42Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrolysis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK303962AA 1961-07-11 1962-07-07 Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-2(1H)-oner. DK107168C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US123964A US3202699A (en) 1961-07-11 1961-07-11 Carbobenzoxyglycylamino-benzophenones

Publications (1)

Publication Number Publication Date
DK107168C true DK107168C (da) 1967-05-01

Family

ID=22411964

Family Applications (1)

Application Number Title Priority Date Filing Date
DK303962AA DK107168C (da) 1961-07-11 1962-07-07 Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-2(1H)-oner.

Country Status (10)

Country Link
US (1) US3202699A (da)
CH (1) CH414655A (da)
DE (1) DE1445863A1 (da)
DK (1) DK107168C (da)
ES (1) ES279296A1 (da)
FI (1) FI45973C (da)
GB (1) GB985683A (da)
MY (1) MY6600019A (da)
OA (1) OA00934A (da)
SE (1) SE301977B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534081A (en) * 1967-07-10 1970-10-13 American Home Prod ((2-benzoylphenylcarbamoyl) methyl) carbamic acid esters
BE757598A (fr) * 1969-10-17 1971-04-16 Hoffmann La Roche Derives de diarylmethanes
GB1433103A (en) * 1974-03-20 1976-04-22 Lepetit Spa Pharmacologically active pyrrolodiazepines
JPS5823382B2 (ja) * 1975-01-20 1983-05-14 三共株式会社 2− アミノアセトアミド − アルフア − フエニルベンジリデンアミノアルカノ−ルユウドウタイノセイゾウホウ
FR2403330A1 (fr) * 1977-06-16 1979-04-13 Fabre Sa Pierre Nouveaux derives de benzoyl-2-chloro-4-glycinanilides substitues, leur procede de preparation et leur application en tant que medicaments
FR2436776A1 (fr) * 1978-09-25 1980-04-18 Fabre Sa Pierre Nouveaux derives d'ortho chloro benzoyl-2 chloro-4 glycylanilide, leur preparation et leur application en tant que medicaments
US4472435A (en) * 1980-07-31 1984-09-18 Hoffman-La Roche Inc. Benzophenone derivatives useful in treating heart failure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2852553A (en) * 1955-10-28 1958-09-16 Monsanto Chemicals Production of nitrosophenylaminoacid esters
US2895927A (en) * 1957-07-05 1959-07-21 Hoffmann La Roche Synthesis of thyronine compounds
US2999091A (en) * 1959-10-23 1961-09-05 Abbott Lab 3,9-diazabicyclo[4.2.1]nonane derivatives

Also Published As

Publication number Publication date
MY6600019A (en) 1966-12-31
SE301977B (da) 1968-07-01
FI45973C (fi) 1972-11-10
GB985683A (en) 1965-03-10
OA00934A (fr) 1968-03-22
DE1445863A1 (de) 1969-03-13
ES279296A1 (es) 1963-04-16
FI45973B (da) 1972-07-31
CH414655A (de) 1966-06-15
US3202699A (en) 1965-08-24

Similar Documents

Publication Publication Date Title
DK104168C (da) Fremgangsmåde til fremstilling af mono-biguanider.
DK127600B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 3-substituerede 2H-1,4-benzodiazepin-2-oner.
DK118242B (da) Fremgangsmåde til fremstilling af anhydropenicilliner.
DK108976C (da) Fremgangsmåde til fremstilling af hendecapeptider.
DK107168C (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-2(1H)-oner.
DK107027C (da) Fremgangsmåde til fremstilling af 3-hydroxy-benzisoxazoler.
DK108227C (da) Fremgangsmåde til fremstilling af 3-carbonhydridoxy-17α-halogenethinyl-19-nor-3,5-androstadien-17β-oler.
DK124753B (da) Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.
DK106554C (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-2(1H)-thioner.
DK106184C (da) Fremgangsmåde til fremstilling af alkylaralkylftalater.
DK118082B (da) Fremgangsmåde til fremstilling af 4-cyanthiazol.
DK103778C (da) Fremgangsmåde til fremstilling af 1-substituerede cycloheptimidazol-2-(1H)-on-forbindelser.
DK120346B (da) Fremgangsmåde til fremstilling af 5-aryl-7-nitro-3H-1, 4-benzodiazepin-2(1H)-oner.
DK104347C (da) Fremgangsmåde til fremstilling af 16α-hydroxysteroider.
DK104136C (da) Fremgangsmåde til fremstilling af benzensulfonylsemicarbazider.
DK104055C (da) Fremgangsmåde til fremstilling af 6-methoxytetraloner.
DK116280B (da) Fremgangsmåde til fremstilling af 4,5-dehydro-3-keto-19-nor-steroider.
DK98328C (da) Fremgangsmåde til fremstilling af 3α-acyloxy-11-oxo-20,20-bis-phosphatomethyl-21-hydroxy-5β-pregnaner.
DK99508C (da) Fremgangsmåde til fremstilling af 7-halogen-2-dimethylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxider.
DK131723B (da) Analogifremgangsmåde til fremstilling af 3-substituerede 2H-1,4-benzodiazepin-2-oner.
DK96599C (da) Fremgangsmåde til fremstilling af 7α-alkylthio-3-keto-4-androsten- eller 7α-alkylthio-3-keto-1,4-androstadienforbindelser.
DK103398C (da) Fremgangsmåde til fremstilling af 1-substituerede cykloheptimidazol-2(1H)-on-forbindelser.
DK104628C (da) Fremgangsmåde til fremstilling af 2-oxo- eller 2-thiono-4,5-D-glucopyrano-tetrahydroimidazolderivater.
DK98559C (da) Fremgangsmåde til fremstilling af 17α-hydroxy-16-methylen-3,20-diketo-4,6-pregnadienderivater.
DK98497C (da) Fremgangsmåde til fremstilling af 17α-hydroxy-16-methylen-6-methyl-3,20-diketo-4,6-pregnadienderivater.